Serina Therapeutics Inc. (SER)
NYSE: SER
· Real-Time Price · USD
4.88
-0.27 (-5.24%)
At close: Oct 16, 2025, 3:59 PM
4.79
-1.84%
After-hours: Oct 16, 2025, 07:58 PM EDT
-5.24% (1D)
| Bid | 4.75 |
| Market Cap | 50.02M |
| Revenue (ttm) | 130K |
| Net Income (ttm) | -12.59M |
| EPS (ttm) | -0.92 |
| PE Ratio (ttm) | -5.3 |
| Forward PE | -2.88 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 5.19 |
| Volume | 19,600 |
| Avg. Volume (20D) | 126,657 |
| Open | 5.08 |
| Previous Close | 5.15 |
| Day's Range | 4.88 - 5.10 |
| 52-Week Range | 3.81 - 8.05 |
| Beta | 0.75 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for SER stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-0.18%
Serina Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
3 months ago
+2.91%
Serina Therapeutics shares are trading higher on possible continued strength after HC Wainwright & Co. initiated coverage on the stock yesterday with a Buy rating and announced a price target of $15.
2 months ago · seekingalpha.com
Seres Therapeutics: Speculative Gem Backed By SER‑155 FDA BreakthroughSeres Therapeutics's VOWST divestiture injected cash, retired debt, and refocused the company as a clinical‑stage microbiome specialist. Their current lead candidate is SER‑155, which seems to reduce ...